News

News
Other news

Analytics 4 Life and Actelion to Develop New Diagnostics for Pulmonary Hypertension

Read full story
Partner news

BiomX Enters Collaboration with Johnson & Johnson Innovation for Discovery of Microbiome-based Biomarkers for IBD

Read full story
Partner news

Vect-Horus Announces Agreement With Johnson & Johnson Innovation

Read full story
JNJ Press releases

Janssen Affiliate Cilag GmbH International Enters Worldwide Collaboration and License Agreement with argenx for Cancer Immunotherapy Cusatuzumab

Read full story
In the media

Slush 2018 highlights: healthtech and life-science side-events and program

Read full story
Partner news

ViaCyte Secures $80 Million Financing to Advance Functional Cures for Insulin-Requiring Diabetes

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Winners of the Seoul Innovation QuickFire Challenge: Robotics & Digital Surgery in Collaboration with Seoul Metropolitan Government and KHIDI

Read full story
JNJ Press releases

Johnson & Johnson Innovation Announces Winners of the Seoul Innovation QuickFire Challenge: Robotics & Digital Surgery in Collaboration with Seoul Metropolitan Government and KHIDI

Read full story
Partner news

Ad Scientiam announces agreement with Johnson & Johnson Innovation to develop a digital assessment scale for Major Depressive Disorders

Read full story
JNJ Press releases

Johnson & Johnson Innovation announces extension of JJIPO @ QUT in collaboration with Queensland State Government to further boost life-science innovation in Queensland

Read full story
Partner news

Arrowhead Pharmaceuticals Announces Closing of Agreements with Janssen

Read full story
Partner news

Carrot Inc. Raises $25 Million to Commercialize Pivot, the Company's Digital Health Solution for Smoking Cessation

Read full story
Partner news

Touchlight announces collaboration with Janssen Biotech

Read full story
JNJ Press releases

Johnson & Johnson Innovation Launches Champions of Science Storytelling Challenge – Latin America & Caribbean Edition

Read full story
Partner news

CuraSen Therapeutics Announces $54.5 Million Series A Financing with Industry Veterans at Helm to Develop Drugs Targeting Novel Mechanism for the Treatment of Neurodegenerative Diseases

Read full story